These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 37689158)
1. The pro-oncogenic protein IF Sgarbi G; Righetti R; Del Dotto V; Grillini S; Giorgio V; Baracca A; Solaini G Biochim Biophys Acta Mol Basis Dis; 2024 Jan; 1870(1):166879. PubMed ID: 37689158 [TBL] [Abstract][Full Text] [Related]
2. The F1Fo-ATPase inhibitor, IF1, is a critical regulator of energy metabolism in cancer cells. Solaini G; Sgarbi G; Baracca A Biochem Soc Trans; 2021 Apr; 49(2):815-827. PubMed ID: 33929490 [TBL] [Abstract][Full Text] [Related]
3. The ATPase Inhibitory Factor 1 (IF1): A master regulator of energy metabolism and of cell survival. García-Bermúdez J; Cuezva JM Biochim Biophys Acta; 2016 Aug; 1857(8):1167-1182. PubMed ID: 26876430 [TBL] [Abstract][Full Text] [Related]
4. The role of the ATPase inhibitor factor 1 (IF Sgarbi G; Barbato S; Costanzini A; Solaini G; Baracca A Biochim Biophys Acta Bioenerg; 2018 Feb; 1859(2):99-109. PubMed ID: 29097244 [TBL] [Abstract][Full Text] [Related]
5. The Multifaceted ATPase Inhibitory Factor 1 (IF1) in Energy Metabolism Reprogramming and Mitochondrial Dysfunction: A New Player in Age-Associated Disorders? Gore E; Duparc T; Genoux A; Perret B; Najib S; Martinez LO Antioxid Redox Signal; 2022 Aug; 37(4-6):370-393. PubMed ID: 34605675 [No Abstract] [Full Text] [Related]
6. PKA Phosphorylates the ATPase Inhibitory Factor 1 and Inactivates Its Capacity to Bind and Inhibit the Mitochondrial H(+)-ATP Synthase. García-Bermúdez J; Sánchez-Aragó M; Soldevilla B; Del Arco A; Nuevo-Tapioles C; Cuezva JM Cell Rep; 2015 Sep; 12(12):2143-55. PubMed ID: 26387949 [TBL] [Abstract][Full Text] [Related]
7. The ATPase Inhibitory Factor 1 (IF1) Contributes to the Warburg Effect and Is Regulated by Its Phosphorylation in S39 by a Protein Kinase A-like Activity. Cuezva JM; Domínguez-Zorita S Cancers (Basel); 2024 Feb; 16(5):. PubMed ID: 38473373 [TBL] [Abstract][Full Text] [Related]
8. The Pro-Oncogenic Protein IF Righetti R; Grillini S; Del Dotto V; Costanzini A; Liuzzi F; Zanna C; Sgarbi G; Solaini G; Baracca A Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834071 [TBL] [Abstract][Full Text] [Related]
9. The mitochondrial inhibitor IF1 binds to the ATP synthase OSCP subunit and protects cancer cells from apoptosis. Galber C; Fabbian S; Gatto C; Grandi M; Carissimi S; Acosta MJ; Sgarbi G; Tiso N; Argenton F; Solaini G; Baracca A; Bellanda M; Giorgio V Cell Death Dis; 2023 Jan; 14(1):54. PubMed ID: 36690622 [TBL] [Abstract][Full Text] [Related]
10. IF1 Promotes Cellular Proliferation and Inhibits Oxidative Phosphorylation in Mouse Embryonic Fibroblasts under Normoxia and Hypoxia. Lauterboeck L; Kang SW; White D; Bao R; Mobasheran P; Yang Q Cells; 2024 Mar; 13(6):. PubMed ID: 38534395 [TBL] [Abstract][Full Text] [Related]
11. The inhibitor protein (IF1) of the F1F0-ATPase modulates human osteosarcoma cell bioenergetics. Barbato S; Sgarbi G; Gorini G; Baracca A; Solaini G J Biol Chem; 2015 Mar; 290(10):6338-48. PubMed ID: 25605724 [TBL] [Abstract][Full Text] [Related]
12. Up-regulation of the ATPase inhibitory factor 1 (IF1) of the mitochondrial H+-ATP synthase in human tumors mediates the metabolic shift of cancer cells to a Warburg phenotype. Sánchez-Cenizo L; Formentini L; Aldea M; Ortega AD; García-Huerta P; Sánchez-Aragó M; Cuezva JM J Biol Chem; 2010 Aug; 285(33):25308-13. PubMed ID: 20538613 [TBL] [Abstract][Full Text] [Related]
13. The Mitochondrial ATP Synthase/IF1 Axis in Cancer Progression: Targets for Therapeutic Intervention. Domínguez-Zorita S; Cuezva JM Cancers (Basel); 2023 Jul; 15(15):. PubMed ID: 37568591 [TBL] [Abstract][Full Text] [Related]
14. A Review of the Inhibition of the Mitochondrial ATP Synthase by IF1 García-Aguilar A; Cuezva JM Front Physiol; 2018; 9():1322. PubMed ID: 30283362 [TBL] [Abstract][Full Text] [Related]
15. The inhibitor protein IF Carroll J; Watt IN; Wright CJ; Ding S; Fearnley IM; Walker JE J Biol Chem; 2024 Mar; 300(3):105690. PubMed ID: 38280428 [TBL] [Abstract][Full Text] [Related]
16. Peptides Targeting the IF1-ATP Synthase Complex Modulate the Permeability Transition Pore in Cancer HeLa Cells. Grandi M; Fabbian S; Solaini G; Baracca A; Bellanda M; Giorgio V Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731874 [TBL] [Abstract][Full Text] [Related]
17. Neuroprotective effects of ATPase inhibitory factor 1 preventing mitochondrial dysfunction in Parkinson's disease. Chung I; Park HA; Kang J; Kim H; Hah SM; Lee J; Kim HS; Choi WS; Chung JH; Shin MJ Sci Rep; 2022 Mar; 12(1):3874. PubMed ID: 35264673 [TBL] [Abstract][Full Text] [Related]
18. Investigation of the role and mechanism of IF1 and STF1 proteins, twin inhibitory peptides which interact with the yeast mitochondrial ATP synthase. Venard R; Brèthes D; Giraud MF; Vaillier J; Velours J; Haraux F Biochemistry; 2003 Jun; 42(24):7626-36. PubMed ID: 12809520 [TBL] [Abstract][Full Text] [Related]
19. Regulation of the H Esparza-Moltó PB; Nuevo-Tapioles C; Cuezva JM Cell Mol Life Sci; 2017 Jun; 74(12):2151-2166. PubMed ID: 28168445 [TBL] [Abstract][Full Text] [Related]
20. Glucose-modulated mitochondria adaptation in tumor cells: a focus on ATP synthase and inhibitor Factor 1. Domenis R; Bisetto E; Rossi D; Comelli M; Mavelli I Int J Mol Sci; 2012; 13(2):1933-1950. PubMed ID: 22408432 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]